我们持续不断在研究和创新。阅读以下内容，了解我们的最新发现和见解。
ENDRA presents AASLD Symposium with Dr Malik and Dr Kowdley on non invasive diagnostic of NAFLD and the current and future therapies in NASH
Watch the Video >
ENDRA presents AASLD Symposium with Dr Malik and Dr Kowdley on non invasive diagnostic of NAFLD and the current and future therapies in NASH
2020 Presentation by Raza Malik, M.D., Ph.D.
Watch the video >
2020 Presentation by Raza Malik, M.D., Ph.D.
Presentation by Raza Malik, M.D., Ph.D.
Francois Michelon, CEO of ENDRA Life Sciences Inc., explains how ENDRA is leading early detection of liver diseases and issues with existing tools’ diagnostic and accessibility properties.
Watch the video >
Francois Michelon, CEO of ENDRA Life Sciences Inc., explains how ENDRA is leading early detection of liver diseases and issues with existing tools’ diagnostic and accessibility properties.
Francois Michelon, CEO of ENDRA Life Sciences Inc., discusses childhood obesity and the risks of NAFLD.
Watch the Video >
Francois Michelon, CEO of ENDRA Life Sciences Inc., discusses childhood obesity and the risks of NAFLD.
Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ technology can help detect and monitor NAFLD-NASH caused by hepatitis.
Watch the video >
Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ technology can help detect and monitor NAFLD-NASH caused by hepatitis.
Renaud Maloberti, CCO of ENDRA Life Sciences Inc., talks about the importance of early diagnosis and access to healthcare.
Watch the video >
Renaud Maloberti, CCO of ENDRA Life Sciences Inc., talks about the importance of early diagnosis and access to healthcare.
Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ is focused on early detection of liver disease by measuring liver fat.
Watch the video >
Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about how TAEUS™ is focused on early detection of liver disease by measuring liver fat.
Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about the significance of CE Mark certification.
Watch the video >
Francois Michelon, CEO of ENDRA Life Sciences Inc., talks about the significance of CE Mark certification.
ENDRA Life Sciences 积极与学术机构和私人研究机构进行外部研究合作。ENDRA Life Sciences 的政策是，通过赞助研究协议、合作研究协议或其他与研究相关的协议，将与其向任何研究组织所提供之任何研究经费相关的间接费用限制在不超过 15%。
ENDRA 不能提供超过合约研究金额百分之十五（15%）的营业费用、间接费用或其他研究相关费用。
ENDRA operates a Quality Management System which complies with the requirements of ISO 13485:2016 & EN ISO 13485:2016 for the following scope:
Certificate number: MD 697226
Effective Date: 2025-04-02
Expiry Date: 2028-04-01
